Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 3

Todd Neale

March 14, 2022

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

L.A. McKeown

August 20, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

COVID-19: TCTMD’s Daily Dispatch for April Week 5

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March Week 5

Shelley Wood

March 29, 2021

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

L.A. McKeown

June 08, 2020

News Daily News

New Wuhan Data Confirm High Hypertension Rate in COVID-19 Deaths

Todd Neale

April 10, 2020

News Daily News

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Yael L. Maxwell

March 26, 2020

News Daily News

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

Michael O'Riordan

March 20, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Michael O'Riordan

October 18, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News ESC 2019

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Michael O'Riordan

September 02, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

Advertisement

December 2025 Dispatch for the CV Team

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

INOCA May Be at the Root of Angina for Many Long-COVID Patients

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

COVID-19: TCTMD’s Dispatch for March Week 3

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

COVID-19: TCTMD’s Daily Dispatch for March Week 5

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

New Wuhan Data Confirm High Hypertension Rate in COVID-19 Deaths

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Recurrent Events Common Among Young Patients With CAD

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content